Both in Biotechnology
Candel Therapeutics vs Sana Biotechnology
Over the past year CADL returned +76.4% and SANA returned −38.3%; their daily moves had a correlation of 0.46.
CADL +76.4% SANA −38.3%Growth of $1, one year, split-adjusted
| Metric | CADL | SANA |
|---|---|---|
| Price | $9.05 | $2.56 |
| Market cap | $692.5M | $766.4M |
| Today | +2.61% | +4.92% |
| 1 month | −8.3% | −6.9% |
| 6 months | +18.6% | −29.7% |
| Year to date | +60.2% | −37.1% |
| 1 year | +73.4% | −44.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $153.7M | $160.5M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 72.6% |
| Short % of float | 21.5% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).